-
Comparative Clinical Effectiveness of Analgesics for the Treatment of Moderate-to-Severe Acute Pain: A Systematic Review and Network Meta-Analysis
Mar 10, 2025, 14:00 PM -
The Cost-effectiveness Analysis of Gene Therapy for Severe Hemophilia B Patients in China: A Microsimulation Experiment Study
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Evaluation of Machine Learning Assisted Title and Abstract Screening in 5 Clinical Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Estimating the Burden of Illness and Healthcare Costs Among Incident Intermittent Catheter Users: A Comparison of Neurogenic and Non-Neurogenic Bladder Cohorts in the US
Mar 10, 2025, 14:00 PM -
Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Evaluating the ROI of a Virtual Maternity Care Initiative Across Medicaid Plans in a Single State
Mar 10, 2025, 14:00 PM -
Cost-Efficiency Modeling of Conversion to Biosimilar Trastuzumab-qyyp in Early-Stage Breast Cancer in Medicare
Mar 10, 2025, 14:00 PM -
Predicted Lifetime Health Care Resource Use Costs Associated With The Treatment Of Patients With Primary Biliary Cholangitis From A UK Payer Perspective
Mar 10, 2025, 14:00 PM -
A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices
Mar 10, 2025, 14:00 PM -
Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)
Mar 10, 2025, 14:00 PM -
Ongoing Accelerated Approval Trends and What It Means for Patients
Mar 10, 2025, 14:00 PM -
Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Correlation Between Price and Prevalence in Non-Oncology Orphan Products With Recent Trends (2015-2024)
Mar 10, 2025, 14:00 PM -
More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Mar 10, 2025, 14:00 PM -
Leveraging AI/Technology in Survey Design, Deployment, and Analysis
Mar 10, 2025, 14:00 PM -
Content Validation of the Most Bothersome Symptom - Essential Tremor Questionnaire (MBS-ET): A Cognitive Debriefing Study
Mar 10, 2025, 14:00 PM
